Original Research
Accepted on 16 Oct 2024
Radiomic Features on PET/CT Imaging of Large B cell Lymphoma Lesions Predicts CAR T-cell Therapy Efficacy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1485039
Type at least 3 characters
1,744 articles
Articles
Methods
Published on 14 Oct 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1458449
- 778 views
Systematic Review
Published on 11 Oct 2024
Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1467740
- 382 views
Brief Research Report
Published on 09 Oct 2024
Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1432310
- 715 views
Correction
Published on 09 Oct 2024
Corrigendum: Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472773
- 312 views
Correction
Accepted on 03 Oct 2024
Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504102
Original Research
Published on 02 Oct 2024
Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1398331
- 638 views
Original Research
Published on 01 Oct 2024
The impact of delayed versus early administration of granulocyte colony-stimulating factor following autologous hematopoietic stem cell transplantation on transplantation outcome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1468948
- 453 views
Case Report
Accepted on 30 Sep 2024
Case Report: HSV Lymphadenitis in Immunocompromised Patient with CLL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1401208
Case Report
Published on 26 Sep 2024
Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1419485
- 350 views
Brief Research Report
Published on 24 Sep 2024
Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1394443
- 682 views
Original Research
Published on 23 Sep 2024
Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1438052
- 741 views
Original Research
Published on 23 Sep 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1466803
- 871 views
Review
Published on 23 Sep 2024
Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1469178
- 693 views
Original Research
Published on 19 Sep 2024
Sorafenib maintenance after allogeneic stem cell transplantation in patients with FLT3+ AML receiving midostaurin during induction and consolidation: a retrospective analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1441254
- 595 views
Case Report
Published on 16 Sep 2024
Case report: Combination therapy with selinexor, decitabine and half-dose CAG regimen for relapsed elderly acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1391329
- 572 views